Marketing-authorisation holder · Spain
Hospira Invicta S.A.
7 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
7 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PACLITAXEL HOSPIRA 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG6 mg · Concentrado para solución para perfusión | Paclitaxel | Spain | Marketed | 2004 |
| TOMUDEX 2 MG POLVO PARA SOLUCION PARA PERFUSION2 mg · Polvo para solución para perfusión | Raltitrexed | Spain | Marketed | 1997 |
| VIBRACINA 10 mg/ml SUSPENSIÓN ORAL11,560 mg · Suspensión oral | Doxycycline | Spain | Marketed | 1968 |
| VIBRACINA 100 mg CÁPSULAS DURAS115,610 mg · Cápsula dura | Doxycycline | Spain | Marketed | 1968 |
| DOBUTAMINA HOSPIRA 12,5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG250 mg · Concentrado para solución para perfusión | Dobutamine | Spain | Withdrawn | 1998 |
| PROTAMINA HOSPIRA 10 mg/ml SOLUCION INYECTABLE50 mg · Solución inyectable | Protamine | Spain | Withdrawn | 1968 |
| VIBRAVENOSA 100 MG SOLUCION INYECTABLE Y PARA PERFUSIÓN25,37 mg · Solución inyectable | Doxycycline | Spain | Withdrawn | 1972 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 7 | 4 | 3 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.